Stockscreener 앱 받기
29.21
1.78%
0.51
시장 영업 전:
30.09
0.88
+3.01%
전일 마감가:
$28.70
열려 있는:
$29.3
하루 거래량:
57,155
Relative Volume:
0.20
시가총액:
$39.15M
수익:
-
순이익/손실:
$-24.14M
주가수익비율:
-2.0887
EPS:
-13.985
순현금흐름:
$-22.40M
1주 성능:
-7.88%
1개월 성능:
-9.51%
6개월 성능:
+113.60%
1년 성능:
+218.89%
1일 변동 폭
$25.78
$29.30
1주일 범위
$25.78
$32.30
52주 변동 폭
$5.25
$36.76
센세이 바이오테라 Stock (SNSE) Company Profile
명칭
Sensei Biotherapeutics Inc
전화
(240) 243-8000
주소
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
29.21 | 38.47M | 0 | -24.14M | -22.40M | -13.98 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
센세이 바이오테라 Stock (SNSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2021-07-01 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-06-29 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-03-01 | 개시 | Berenberg | Buy |
| 2021-03-01 | 개시 | Citigroup | Buy |
| 2021-03-01 | 개시 | Oppenheimer | Outperform |
| 2021-03-01 | 개시 | Piper Sandler | Overweight |
모두보기
센세이 바이오테라 주식(SNSE)의 최신 뉴스
Sensei Biotherapeutics (SNSE) details Faeth acquisition, PIPE and going-concern warning - Stock Titan
Sensei Biotherapeutics (SNSE) grants PFO 80,000 stock options - Stock Titan
Director at Sensei Biotherapeutics (SNSE) receives 23,100 stock options - Stock Titan
Sensei Biotherapeutics Inc and Faeth Therapeutics Acquisition Call Transcript - GuruFocus
Macro Review: Is Sensei Biotherapeutics Inc in a bullish channel2026 Trading Recap & Community Consensus Trade Signals - baoquankhu1.vn
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options - MSN
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - BioSpace
Aug Update: What is the Moat Score of Sensei Biotherapeutics IncQuarterly Market Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Investor Mood: What is the Moat Score of Sensei Biotherapeutics IncQuarterly Profit Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Sidley Represents Sensei Biotherapeutics in Acquisition of Faeth Therapeutics - Legal Desire Media and Insights
AI Stocks: Can Sensei Biotherapeutics Inc grow without dilution2026 Catalysts & Trade Opportunity Analysis Reports - baoquankhu1.vn
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update - biospace.com
Sensei Biotherapeutics (SNSE) Sets Ambitious Clinical Goals for 2026 - GuruFocus
Faeth acquisition and $200M raise reshape Sensei Biotherapeutics (NASDAQ: SNSE) - stocktitan.net
Sensei Biotherapeutics Acquires Faeth, Advances PIKTOR Cancer Program with $200M Financing and Reports 2025 Financial Results - Minichart
Sensei Biotherapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update - TradingView
Sensei Biotherapeutics (NASDAQ: SNSE) 2025 loss narrows, lands $200M - Stock Titan
Aug Chart Watch: What is Sensei Biotherapeutics Incs TAM Total Addressable Market2026 WrapUp & Real-Time Market Trend Scan - baoquankhu1.vn
If You Invested $1,000 in Sensei Biotherapeutics, Inc. (SNSE) - Stock Titan
Decliners Report: Does Sensei Biotherapeutics Inc have pricing power2026 Sector Review & Long-Term Safe Investment Plans - baoquankhu1.vn
Aug Technicals: What is the Moat Score of Sensei Biotherapeutics Inc2026 PreEarnings & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Momentum Shift: Can Sensei Biotherapeutics Inc be the next market leaderWeekly Profit Recap & Capital Efficient Trade Techniques - baoquankhu1.vn
SNSE.O PE Ratio & Valuation, Is SNSE.O Overvalued - Intellectia AI
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology - GlobeNewswire Inc.
Anand Kiran Parikh Net Worth (2026) - GuruFocus
Sensei Biotherapeutics announces inducement grants under Nasdaq listing rule - TipRanks
Sensei Biotherapeutics (SNSE) Announces Stock Option Grant to Ne - GuruFocus
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Sensei Biotherapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Why Sensei Biotherapeutics Inc. stock is favored by pension funds2026 Pullbacks & Reliable Entry Point Trade Alerts - Naître et grandir
Update Recap: How buybacks impact Sensei Biotherapeutics Inc. stock valueCEO Change & Comprehensive Market Scan Insights - Naître et grandir
Published on: 2026-03-07 01:25:22 - Naître et grandir
Can Sensei Biotherapeutics Inc be the next market leaderQuarterly Profit Review & Technical Confirmation Alerts - baoquankhu1.vn
Rate Hike: Is Sensei Biotherapeutics Inc a strong growth stockMarket Activity Recap & Stepwise Trade Execution Plans - baoquankhu1.vn
Fed Meeting: Whats next for CRWD stock2025 Market WrapUp & Accurate Entry/Exit Alerts - baoquankhu1.vn
Trails Edge Capital Partners, LP Acquires Shares in Sensei Bioth - GuruFocus
Revenue Check: Is Sensei Biotherapeutics Inc being accumulated by smart moneyWeekly Gains Summary & Accurate Buy Signal Notifications - baoquankhu1.vn
Sensei Biotherapeutics grants stock options to 17 new employees - Investing.com
SNSE (NASDAQ: SNSE) insider schedules sale of 3,374 shares; prior sale 42,594 - Stock Titan
SNSE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sensei Biotherapeutics Acquires Faeth Therapeutics and Raises US$200 Million in Private Placement - Global Legal Chronicle
SNSESensei Biotherapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Sensei Biotherapeutics Merges with Faeth Therapeutics, Secures $200M Funding - National Today
What is Sensei Biotherapeutics Inc. s revenue forecastJuly 2025 Trade Ideas & Precise Buy Zone Tips - mfd.ru
Sensei Biotherapeutics Acquires Faeth Therapeutics - Global Legal Chronicle
Sensei Biotherapeutics (SNSE) COO and director added as SEC insider - Stock Titan
Sensei Biotherapeutics Closes Faeth Acquisition and Financing - The Globe and Mail
Sensei Biotherapeutics Secures Future with Faeth Therapeutics Acquisition and $200M Financing - Beijing Times
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition - MSN
센세이 바이오테라 (SNSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):